Trexquant Investment LP Intercept Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

$6.33 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.99 - $18.71 $164,315 - $307,742	16,448 New	16,448 $304,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $138,794 - $240,481	11,077 Added 11.3%	109,078 $1.46 Million
Q4 2022 Feb 13, 2023	SELL	$11.61 - $16.11 $21,490 - $29,819	-1,851 Reduced 1.85%	98,001 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $485,115 - $782,700	39,731 Added 66.09%	99,852 $1.39 Million
Q2 2022 Aug 11, 2022	BUY	$11.23 - $19.59 $675,158 - $1.18 Million	60,121 New	60,121 $830,000
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $497,500 - $680,405	-34,839 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $452,558 - $713,154	34,839 New	34,839 $517,000
Q2 2021 Aug 12, 2021	SELL	$15.46 - $24.5 $417,481 - $661,598	-27,004 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$19.33 - $37.75 $521,987 - $1.02 Million	27,004 New	27,004 $623,000
Q4 2020 Feb 11, 2021	SELL	$24.48 - $42.47 $425,633 - $738,425	-17,387 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$39.09 - $53.44 $679,657 - $929,161	17,387 New	17,387 $721,000
Q2 2020 Aug 07, 2020	SELL	$46.7 - $92.04 $496,888 - $979,305	-10,640 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$48.35 - $118.68 $514,444 - $1.26 Million	10,640 New	10,640 $670,000
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $529,260 - $1.15 Million	-9,227 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$58.69 - $80.46 $431,312 - $591,300	-7,349 Reduced 44.34%	9,227 $612,000
Q2 2019 Aug 09, 2019	SELL	$77.77 - $120.68 $694,719 - $1.08 Million	-8,933 Reduced 35.02%	16,576 $1.32 Million
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $1.24 Million - $1.62 Million	13,450 Added 111.53%	25,509 $2.85 Million
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $1.03 Million - $1.52 Million	12,059 New	12,059 $1.22 Million
Q2 2018 Aug 07, 2018	SELL	$60.0 - $85.67 $2.23 Million - $3.19 Million	-37,238 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$52.72 - $67.25 $1.96 Million - $2.5 Million	37,238 New	37,238 $2.29 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account